Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice
Standard
Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice. / Knips, Jillian; Czech-Sioli, Manja; Spohn, Michael; Heiland, Max; Moll, Ingrid; Grundhoff, Adam; Schumacher, Udo; Fischer, Nicole.
in: INT J CANCER, Jahrgang 141, Nr. 1, 01.07.2017, S. 160-171.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice
AU - Knips, Jillian
AU - Czech-Sioli, Manja
AU - Spohn, Michael
AU - Heiland, Max
AU - Moll, Ingrid
AU - Grundhoff, Adam
AU - Schumacher, Udo
AU - Fischer, Nicole
N1 - © 2017 UICC.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Merkel cell carcinoma (MCC) is an aggressive skin cancer entity that frequently leads to rapid death due to its high propensity to metastasize. The etiology of most MCC cases is linked to Merkel cell polyomavirus (MCPyV), a virus which is monoclonally integrated in up to 95% of tumors. While there are presently no animal models to study the role of authentic MCPyV infection on transformation, tumorigenesis or metastasis formation, xenograft mouse models employing engrafted MCC derived cell lines (MCCL) represent a promising approach to study certain aspects of MCC pathogenesis. Here, the two MCPyV positive MCC cell lines WaGa and MKL-1 were subcutaneously engrafted in scid mice. Engraftment of both MCC cell lines resulted in the appearance of circulating tumor cells and metastasis formation, with WaGa-engrafted mice showing a significantly shorter survival time as well as increased numbers of spontaneous lung metastases compared to MKL-1 mice. Interestingly, explanted tumors compared to parental cell lines exhibit an upregulation of MCPyV sT-Antigen expression in all tumors, with WaGa tumors showing significantly higher sT-Antigen expression than MKL-1 tumors. RNA-Seq analysis of explanted tumors and parental cell lines furthermore revealed that in the more aggressive WaGa tumors, genes involved in inflammatory response, growth factor activity and Wnt signaling pathway are significantly upregulated, suggesting that sT-Antigen is the driver of the observed differences in metastasis formation. This article is protected by copyright. All rights reserved.
AB - Merkel cell carcinoma (MCC) is an aggressive skin cancer entity that frequently leads to rapid death due to its high propensity to metastasize. The etiology of most MCC cases is linked to Merkel cell polyomavirus (MCPyV), a virus which is monoclonally integrated in up to 95% of tumors. While there are presently no animal models to study the role of authentic MCPyV infection on transformation, tumorigenesis or metastasis formation, xenograft mouse models employing engrafted MCC derived cell lines (MCCL) represent a promising approach to study certain aspects of MCC pathogenesis. Here, the two MCPyV positive MCC cell lines WaGa and MKL-1 were subcutaneously engrafted in scid mice. Engraftment of both MCC cell lines resulted in the appearance of circulating tumor cells and metastasis formation, with WaGa-engrafted mice showing a significantly shorter survival time as well as increased numbers of spontaneous lung metastases compared to MKL-1 mice. Interestingly, explanted tumors compared to parental cell lines exhibit an upregulation of MCPyV sT-Antigen expression in all tumors, with WaGa tumors showing significantly higher sT-Antigen expression than MKL-1 tumors. RNA-Seq analysis of explanted tumors and parental cell lines furthermore revealed that in the more aggressive WaGa tumors, genes involved in inflammatory response, growth factor activity and Wnt signaling pathway are significantly upregulated, suggesting that sT-Antigen is the driver of the observed differences in metastasis formation. This article is protected by copyright. All rights reserved.
KW - Journal Article
U2 - 10.1002/ijc.30723
DO - 10.1002/ijc.30723
M3 - SCORING: Journal article
C2 - 28380668
VL - 141
SP - 160
EP - 171
JO - INT J CANCER
JF - INT J CANCER
SN - 0020-7136
IS - 1
ER -